Search for: "Amgen Inc" Results 121 - 140 of 702
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Amgen v. Sanofi: Who Decides Full Scope Enablement
19 Apr 2021, 6:04 am by Dennis Crouch
by Dennis Crouch Amgen Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court to Weigh in on Presumption of Reliance in Securities Class Actions: Goldman Sachs v. Arkansas Teacher Retirement System
12 Apr 2021, 5:55 am
On March 29, the United States Supreme Court heard oral argument in Goldman Sachs Group, Inc., et al. v. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Sixteen state AG's back affirming Second Circuit in Goldman Sachs case
5 Mar 2021, 8:15 am by John Jascob
The petition in Goldman Sachs Group, Inc. v. [read post]
Jim Hamilton's World of Securities Regulation - http://jimhamiltonblog.blogspot.com/
Amgen Inc. v. Sanofi (Fed. Cir. 2021)
21 Feb 2021, 9:59 pm by Patent Docs
Noonan -- A little less than four years ago, the Federal Circuit rendered a decision in Amgen Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
U.S. Federal Circuit Continues To Pressure BioPharma For More When It Comes To Functional Claims
19 Feb 2021, 2:28 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and Dinis Cheian (Ropes & Gray LLP)
In its latest decision on this topic, Amgen Inc. et al. v. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Functional Claim “Raises the Bar for Enablement”
16 Feb 2021, 7:57 pm by Dennis Crouch
Inc., 959 F.3d 1091 (Fed. [read post]
Patently-O - http://patentlyo.com/patent
Buying up Overlapping Patents — and Double Patenting
15 Feb 2021, 9:52 am by Dennis Crouch
by Dennis crouch Sandoz Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Has the Federal Circuit Made It Nearly Impossible to Maintain Genus Claims?
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
This particular case involved a new generation of drugs for the treatment of hepatitis C, where Idenix accused Gilead Sciences, Inc. [read post]
Filewrapper.com - https://www.filewrapper.com/
Judge Connolly Grants Hospira and Pfizer’s Motion to Stay Patent Infringement Action Pending Resolution of Related Action
9 Jan 2021, 9:16 am by Gregory B. Williams
Connolly, in Amgen Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
“Bump-Up Exclusion” Bars Coverage of Settlement of Deal Litigation Claims
17 Oct 2020, 6:58 am
Onyx Pharmaceuticals Inc. v. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Federal Circuit Finds Recombinant Polypeptide Anticipated By Native Polypeptide
6 Oct 2020, 7:55 am by Courtenay C. Brinckerhoff
The decision came in Biogen MA Inc. v. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
Structuring Assignments to Avoid Obviousness-Type-Double-Patenting
29 Sep 2020, 10:23 am by Dennis Crouch
  Roche separately patented its own fusion protein, and Immunex (Amgen) effectively purchased this third patent. [read post]
Patently-O - http://patentlyo.com/patent
Product-by-Process Within a Method Claim
28 Sep 2020, 8:00 am by Dennis Crouch
EMD Serono, Inc. [read post]
Patently-O - http://patentlyo.com/patent
Adding to the Uncertainty of Obviousness-Type Double Patenting
10 Sep 2020, 3:00 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and Monica Ortel (Ropes & Gray LLP)
Sandoz Inc., ___ F.3d ___, No. 2020-1037 (Fed. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Gensetix, Inc. v. Board of Regents of the University of Texas System (Fed. Cir. 2020)
27 Jul 2020, 9:49 pm by Patent Docs
The Federal Circuit, in a fractured decision reminiscent of the alignment of the judges in Amgen v Sandoz, remedied this situation in its decision last Friday in Gensetix, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
The Antitrust Week In Review
27 Jul 2020, 2:04 am by Deb Givens
., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/
CAFC interprets Hatch-Waxman in Genentech v. Immunex
10 Jul 2020, 2:12 pm by Lawrence B. Ebert
Amgen Inc., 137 S. [read post]
IPBiz - http://ipbiz.blogspot.com/
Genentech, Inc. v. Immunex Rhode Island Corp. (Fed. Cir. 2020)
7 Jul 2020, 8:22 pm by Patent Docs
Noonan -- In a procedurally unusual decision (but one unsurprising in all other respects), the Federal Circuit on Monday affirmed a district court's denial of a temporary restraining order to keep off the market Amgen's biosimilar product Mvasi in Genentech, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Upholds Patent for Biologic Drug Enbrel; Judge Reyna Dissents
7 Jul 2020, 9:15 am by Rebecca Tapscott
District Court for the District of New Jersey in Immunex Corporation, Amgen Manufacturing, Limited, Hoffman-La Roche Inc. v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Federal Circuit Upholds Patent for Biologic Drug Enbrel; Judge Reyna Dissents
7 Jul 2020, 9:15 am by Rebecca Tapscott
District Court for the District of New Jersey in Immunex Corporation, Amgen Manufacturing, Limited, Hoffman-La Roche Inc. v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com